Progress on the application of artificial intelligence technology in ligand-based and receptor structure-based drug screening / 药学学报
Acta Pharmaceutica Sinica
; (12): 2136-2145, 2021.
Article
em Zh
| WPRIM
| ID: wpr-887033
Biblioteca responsável:
WPRO
ABSTRACT
Artificial intelligence technology is being widely applied in drug screening. This paper introduces the characteristics of artificial intelligence, and summarizes the application and progress of artificial intelligence technology especially deep learning in drug screening, from ligand-based and receptor structure-based aspects. This paper also introduces how to apply artificial intelligence to drug design from these two aspects. Finally, we discuss the main limitations, challenges, and prospects of artificial intelligence technology in the field of drug screening.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Idioma:
Zh
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2021
Tipo de documento:
Article